Form 8-K Amphastar Pharmaceutical For: May 09

Go back to Form 8-K Amphastar Pharmaceutical For: May 09

Amphastar Pharma (AMPH) Tops Q1 EPS by 15c

May 9, 2016 4:40 PM EDT

Amphastar Pharma (NASDAQ: AMPH) reported Q1 EPS of $0.12, $0.15 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $59.4 million versus the consensus estimate of $62 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

... More